MEN1 and acute myeloid leukemia: Recently, acute myeloid leukemia (AML) with rearrangement of the nucleoporin 98 (NUP98) gene has been found to be sensitive to menin inhibitors, which hold promise to play an important role in this adverse disease subgroup (Figure 1).